FindTrial
Sign In

Indocyanine Green Fluorescence Navigation Versus Conventional Laparoscopic Hepatectomy for Hepatic Hemangioma :A Propensity Score-matched Study

Comparison of current surgical treatments for hepatic hemangioma.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098185
Enrollment
Unknown
Registered
2025-03-04
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic hemangioma

Interventions

Experimental group (Indocyanine Green Fluorescence Navigation Laparoscopic Hepatectomy for Hepatic Hemangioma):NA
control group (Conventional Laparoscopic Hepatectomy for Hepatic Hemangioma):NA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients diagnosed with hepatic hemangioma according to preoperative imaging and postoperative pathology; 2. single or multiple tumors, definite clinical symptoms or asymptomatic patients with rapid tumor diameter increase (average annual increase >=2cm); 3. at the age of 18 to 65; 4. preoperative Child-Pugh score <=7; 5. patients who could undergo both laparoscopic and open resection for the treatment of hepatic hemangioma; 6. Normal cardiopulmonary function.

Exclusion criteria

Exclusion criteria: 1. previous history of upper abdominal surgery; 2. preoperative treatment of hepatic hemangioma; 3. no informed consent; 4. Infectious diseases

Design outcomes

Primary

MeasureTime frame
Blood loss;Operative time;hemoglobin;Bilirubin;WBC;—

Countries

China

Contacts

Public ContactMing Zhang

Division of Liver Surgery, Department of General Surgery,West China Hospital,Sichuan University, China

zmhxdoctor@wchscu.edu.cn+86 189 8060 6723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026